|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
||||||||
| TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: George E. Cox III, JD, Director, Division of Legislative Counsel |
Date | 01/21/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 410, United States Physician Shortage Elimination Act of 2007, provisions relating to workforce and GME
S. 3708, Health Professions and Primary Care Reinvestment Act, provisions relating to workforce, GME, and student loans
Graduate Medical Education - restoration of the 20/220 pathway for economic hardship deferment on student loans
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Government Accountability Office (GAO),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Cary |
Gibson |
|
|
|
Liza |
Assatourians |
|
|
|
George |
Cox |
III |
|
|
Margaret |
Garikes |
|
|
|
Sharon |
McIlrath |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 6898, Health-e Information Technology Act of 2008, all provisions
H.R. 6357, PRO(TECH)T Act of 2008, all provisions
H.R. 6100, Kid-Safe Chemicals Act of 2008, provisions on reducing exposure to toxic chemical substances
S. 3040, Kid-Safe Chemicals Act of 2008, provisions on reducing exposure to toxic chemical substances
H.R. 6845, Fair Copyright in Research Works Act, provision on protection of copyright for NIH-funded research
S. 3408, Comparative Effectiveness Research Act of 2008, all provisions
Organ transplantation - providing incentives to increase organ donation
Patient Safety
Health Savings Accounts
Simplified Medical Billing
Medical Tourism - AMA principles
Comparative Effectiveness Research - AMA principles
Social Security Administration authorization for release of medical records
Patient Safety and Quality Improvement Act regulations
E-prescribing/Health Information Technology
Physician-owned Hospitals
FDA post-marketing surveillance of prescription drugs
Provider Conscience Clause
Uninsured/Health System Reform - AMA Proposal
Domestic Violence and Abuse
Obesity Screening
Chronic Kidney Disease
High Fructose Corn Syrup
Vitamin D - physician guidelines
Baucus Health System Reform proposal
Healthy Lifestyles Initiatives
Economic Stimulus Package
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), Social Security Administration (SSA), Agency for Health Care Policy & Research, Natl Institutes of Health (NIH), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Margaret |
Carvin |
|
|
|
Veronica |
Crowe |
|
|
|
Cary |
Gibson |
|
|
|
Jason |
Marino |
|
|
|
Christine |
Pollack |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Carol |
Vargo |
|
|
|
Liza |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
George |
Cox |
III |
|
|
Kathleen |
Tenoever |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R. 6582, Small Business Cooperative for Healthcare Options to Improve Coverage for Employees Act of 2008, all provisions
FTC Red Flag Rules - identity theft detection programs
Health plan mergers; FTC health policy guidelines
Physician collaboration on HIT & Quality Improvement
Workforce Issues, future supply of physicians
17. House(s) of Congress and Federal agencies Check if None
Federal Trade Commission (FTC), U.S. HOUSE OF REPRESENTATIVES, Justice - Dept of (DOJ), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Margaret |
Carvin |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
Carol |
Vargo |
|
|
|
Liza |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
George |
Cox |
III |
|
|
Carolyn |
Ratner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 7148, Medicare Beneficiary Freedom to Choose Act of 2008, all provisions
S. 2029, Physician Payments Sunshine Act of 2007, all provisions
H.R. 7192, Preserving Patient Access to Primary Care Act, all provisions
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, provisions on transparency, calculation of successful
participation, reform PQRI feedback reports, and quality incentive payment programs
Medicare Program - HIPAA: ICD-10
Medicare Program - HIPAA: electronic transactions version 5010
Medicare Program - Current Procedural Terminology (CPT)
Medicare Program - Regulatory Reform
Medicare Program - NPI enrollment problems
Medicare Program - Medicare Prescription Drugs, price negotiation authority
Medicare Program - Physician Quality Reporting Initiative (PQRI)
Medicare Program - Recovery Audit Contractor (RAC) program
Medicare Program - billing for consultations
Medicare program - billing for audiologists
Medicare Program - Physician Payment Reform/Rebasing SGR/Directed Scoring/Remove Drugs from SGR Calculations
Medicare Program - Balance Billing
Medicare Program - Incident-to billing policies
Medicare Program - SGR Alternatives
Medicare Program - Part D Drugs Program
Medicare Program - Advance Payment Policy
Medicare Program - E-Prescribing
Medicare Program - Uses of Government Claims Data; Medicare Claims Data and BQI Pilots
Medicare Program - Medicare Administrative Contractors (MACs)
Medicare Program - 2009 Medicare physician fee schedule final rule
Medicare Program - Medicare Resource Use Reports
Medicare Program - 2010 Physician Update
Medicare Program - AMA/Specialty Society Relative Value System (RVS) Update Committee's PLI recommendations
Medicare Program - Medicare Advantage
17. House(s) of Congress and Federal agencies Check if None
Centers For Medicare and Medicaid Services (CMS), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Margaret |
Carvin |
|
|
|
Veronica |
Crowe |
|
|
|
Cary |
Gibson |
|
|
|
Jason |
Marino |
|
|
|
Christine |
Pollack |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Mari |
Savickis |
|
|
|
Jennifer |
Shevchek |
|
|
|
Liza |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
George |
Cox |
III |
|
|
Carolyn |
Ratner |
|
|
|
Kathleen |
Tenoever |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
|
Liza |
Assatourians |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
FDA Regulation of Tobacco
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Debra |
Cohn |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
BUD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |